CG Oncology Income Statement (2023-2025) | CGON

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.19M0.01M0.00M0.53M0.11M0.04M0.46M0.05M1.67M
Gross Profit 0.09M
Operating items
Research & Development 7.84M9.83M11.73M16.34M17.21M18.47M19.62M26.80M27.47M31.33M27.88M
Selling, General & Administrative 2.07M2.49M2.32M3.02M5.79M7.49M8.72M11.71M14.79M17.41M23.33M
Other Operating Expenses 1.58M
Operating Expenses 9.91M12.33M14.05M19.36M23.00M25.96M28.34M38.51M42.26M48.74M52.80M
Operating Income -9.72M-12.33M-14.04M-19.36M-22.47M-25.85M-28.30M-38.05M-42.20M-48.74M-51.13M
EBIT -9.72M-12.33M-14.04M-19.36M-22.47M-25.85M-28.30M-38.05M-42.20M-48.74M-51.13M
Non-operating items
Interest & Investment Income 1.05M0.77M2.28M2.80M5.54M6.94M7.89M6.25M7.75M7.32M7.42M
Other Non Operating Income 0.01M-0.06M-0.01M-0.00M-0.01M0.01M-0.00M0.01M0.01M-0.00M-0.10M
Non Operating Income 1.05M0.71M2.27M2.80M5.54M6.95M7.89M6.25M7.75M7.32M7.32M
Net income details
EBT -8.68M-11.55M-11.76M-16.55M-16.93M-18.91M-20.40M-31.80M-34.46M-41.42M-43.71M
Profit After Tax -8.67M-11.61M-11.77M-16.55M-16.93M-18.90M-20.41M-31.80M-34.50M-41.43M-43.81M
Income from Continuing Operations -8.68M-11.55M-11.76M-16.55M-16.93M-18.91M-20.40M-31.80M-34.46M-41.42M-43.71M
Consolidated Net Income -8.68M-11.55M-11.76M-16.55M-16.93M-18.91M-20.40M-31.80M-34.46M-41.42M-43.71M
Income towards Parent Company -8.68M-11.55M-11.76M-16.55M-16.93M-18.91M-20.40M-31.80M-34.46M-41.42M-43.71M
Preferred Dividend Payments 3.73M3.78M5.34M5.93M
Net Income towards Common Stockholders -12.40M-15.39M-17.51M-22.49M-16.93M-18.90M-20.41M-31.80M-34.46M-41.42M-43.71M
Additional items
EPS (Basic) -3.22-3.93-4.00-4.47-0.36-0.28-0.30-0.48-0.45-0.54-0.57
EPS (Weighted Average and Diluted) -3.22-3.93-4.00-4.47-0.36-0.28-0.30-0.48-0.45-0.54-0.57
Shares Outstanding (Weighted Average) 43.48M43.48M43.48M43.48M66.64M66.64M67.08M67.63M76.22M76.23M76.25M
Shares Outstanding (Diluted Average) 3.86M3.92M4.38M4.33M47.06M66.65M67.14M62.50M76.19M76.23M76.73M
EBITDA -9.72M-12.33M-14.04M-19.36M-22.47M-25.85M-28.30M-38.05M-42.20M-48.74M-51.13M
Shares Outstanding 3.86M4.04M5.07M5.22M66.64M66.66M67.54M76.15M76.22M76.23M78.28M